SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, attributed to stronger demand for Amtagvi and Proleukin, is driving the rally and bullish reaction. Traders are also focused on anticipated lung cancer data, while short-squeeze and takeover talk remains speculative.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FHFAs move to let Fannie Mae and Freddie Mac use VantageScore alongside FICO is driving concern that competition could weaken FICOs mortgage-scoring dominance and pricing power. Traders are divided between viewing the selloff as an overreaction and expecting further pressure from market-share and pricing risks.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as long-term Treasury yields surge amid persistent inflation concerns, heavy government borrowing, and expectations that rates will stay higher or rise further. Traders are split between viewing the selloff as an oversold buying opportunity and expecting further losses, while debating whether elevated yields could eventually weigh on stocks.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for a U.S. Army program to develop next-generation silicon-carbide power semiconductors sparked attention, with traders viewing it as technology validation and a potential route to future defense and infrastructure opportunities. The shares sharp reversal after an initial pop fueled debate over whether the awards long-term promise outweighs the lack of disclosed contract value and near-term revenue; some traders also blamed short selling or manipulation, without evidence establishing those claims.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals quarterly earnings beat expectations, with record bookings and stronger full-year guidance driving a sharp share-price jump. Bulls are celebrating the results and demand outlook, while skeptics point to fuel-cost pressures, weaker fourth-quarter expectations and potential profit-taking after the rally.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Rising Treasury yields and persistent inflation concerns are weighing on rate-sensitive Russell 2000 small caps, which traders say are lagging large-cap tech as borrowing and refinancing costs rise. The discussion is broadly bearish, though some see the selloff as oversold and look for a rebound if yields ease.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp Treasury selloff and surging yields are dominating SPY discussion, with traders warning that higher borrowing costs and debt or inflation concerns could pressure stocks. Others point to equities resilience and possible rebounds, leaving the conversation split amid choppy trading.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Jobys Texas eIPP flights and autonomous-flight demonstrations are fueling discussion about progress toward FAA certification and eventual commercialization. Optimists see these milestones and defense opportunities as long-term positives, while skeptics focus on the stocks steep decline, insider selling, dilution risk and continued cash burn.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas strategic investment and oncology-trial collaboration have drawn attention as a source of funding and validation for Summits ivonescimab program. Traders are broadly encouraged, while debating dilution and emphasizing that the deal is not a buyout and does not resolve the separate FDA approval risk.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles sharp rebound is being linked by traders to its NetApp partnership, which brings ONTAP storage capabilities natively to OCI for enterprise and AI workloads. Bulls are celebrating the move and speculating about short-covering, while skeptics question whether the rally will hold and point to the stocks recent volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SBEV Stock Tumbles Over 35% In Pre-Market Today — A Look At Its Latest Deal With Argent BioPharma

Equity

The company secured an exclusive global licensing agreement for CannEpil.

Splash Beverage’s Exclusive Global CannEpil Deal Signals Bold Shift into Biopharmaceuticals

Splash Beverage Group (NYSEAMERICAN:SBEV) is making a dramatic strategic pivot, moving beyond beverages with the acquisition of exclusive worldwide rights to CannEpil®, an investigational cannabinoid-based therapy for drug-resistant epilepsy (DRE). The licensing agreement with Argent BioPharma positions the company to participate in the growing cannabinoid therapeutics market while leveraging an asset that already has international patient access, regulatory engagement, and a potential pathway toward U.S. clinical development.

These Emerging Companies Are Chasing Billion-Dollar Opportunities

The convergence of national security priorities, artificial intelligence expansion, energy infrastructure demands, and space commercialization is creating opportunities for smaller public companies to establish footholds in markets that could ultimately reach hundreds of billions of dollars in value over the coming decade. $BLIS, $XERI, $STI, $STI, $CXAI, $SBEV, $FJET

Can This Tiny Beverage Stock Make a Bigger Splash in the Wellness Market?

The cannabinoid wellness industry continues to attract attention as regulatory frameworks evolve and companies look for strategic ways to capitalize on growing consumer demand. With consolidation activity increasing and public companies seeking new growth avenues, investors are closely watching businesses that can successfully reposition themselves within emerging wellness categories.Shares of Splash Beverage Group, Inc. (NYSE American: SBEV) are making a major move higher in Wednesday trading after the company provided a corporate update on its NYSE American compliance efforts and ongoing ...

Capital Rotation: Why Smart Money is Chasing Functional Wellness

Capital Rotation: Why Smart Money is Chasing Functional Wellness Capital Rotation: Why Smart Money is Chasing Functional Wellness PR Newswire VANCOUVER, BC, Feb. 6, 2026 ISSUED ON BEHALF OF DOSEOLOGY...

Why Did Splash Beverage Stock Rise 28% In Premarket?

Splash Beverage reported nil revenue in its delayed interim Q3 filing, raising grave concerns.

Endovia Health Sciences, Inc. engages in the sale and production of natural and healthy drinks. It offers products under the brands of Salt Tequila and Chispo Tequila. The company was founded on September 3, 1992 and is headquartered in Fort Lauderdale, FL.

Splash Beverage Group Inc

Bullish Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Current Price	$0.2385
Prev Close	$0.2461
Open	$0.2422
Dividend Yield	0.00%
50-Day Moving Average	$0.3546
Beta	1.37
Avg. Volume	3.53M
PE Ratio	0.00

52-Week High	$13.40
52-Week Low	$0.2323
Market Capitalization	$1.58M
EPS (Annual)	-$47.86
Price to Book	-0.06
Revenue Per Employee	$36,533.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

SBEV Fundamentals